Yale Jen analyst LAIDLAW

Currently out of the existing stock ratings of Yale Jen, 22 are a BUY (95.65%), 1 are a HOLD (4.35%).

Yale Jen

Work Performance Price Targets & Ratings Chart

Analyst Yale Jen, currently employed at LAIDLAW, carries an average stock price target met ratio of 35.42% that have a potential upside of 66.8% achieved within 263 days.

Yale Jen’s has documented 42 price targets and ratings displayed on 11 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on SLNO, Soleno Therapeutics at 27-Mar-2025.

Wall Street Analyst Yale Jen

Analyst best performing recommendations are on CRIS (CURIS).
The best stock recommendation documented was for CRIS (CURIS) at 12/8/2020. The price target of $10 was fulfilled within 31 days with a profit of $3.45 (52.67%) receiving and performance score of 16.99.

Average potential price target upside

ARCT Arcturus Therapeutics Holdings CRIS Curis VINC Vincerx Pharma IONS Ionis Pharmaceuticals EVFM Evofem Biosciences TCRT Alaunos Therapeutics SLNO Soleno Therapeutics AFMD Affimed NV EYPT Eyepoint Pharmaceuticals MEIP MEI Pharma BLPH Bellerophon Therapeutics

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$66

$52.67 (395.12%)

$68

1 months 16 days ago
(13-May-2025)

1/6 (16.67%)

$54.14 (456.49%)

75

Buy

$60

$46.67 (350.11%)

$60

2 months 19 days ago
(10-Apr-2025)

14/35 (40%)

$50.65 (541.71%)

165

Buy

3 months 22 days ago
(07-Mar-2025)

3/5 (60%)

$21.39 (65.59%)

559

Buy

$48

$34.67 (260.09%)

$40

1 years 4 months 21 days ago
(08-Feb-2024)

4/8 (50%)

$10.09 (26.62%)

195

Buy

$36

1 years 11 months 15 days ago
(14-Jul-2023)

2/2 (100%)

$15.83 (78.48%)

271

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Yale Jen is most bullish on?

Potential upside of $21.75 has been obtained for SLNO (SOLENO THERAPEUTICS)

What Year was the first public recommendation made by Yale Jen?

On 2014

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?